Rocket says the PRV sale extends its cash runway into the second quarter of 2028. (dima_zel/iStock/Getty Images Plus) Rocket Pharmaceuticals has offloaded its lucrative FDA rare pediatric disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results